Cargando…

Ceftobiprole medocaril

Ceftobiprole medocaril is a broad-spectrum 5th-generation cephalosporin with activity against Gram-positives such as methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae, and against Gram-negatives such as Pseudomonas aeruginosa. The recommended dose is 500 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Méndez, Raúl, Latorre, Ana, González-Jiménez, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2022
Materias:	New Antimicrobial Alternatives in the Treatment of Pneumonia
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106187/ https://www.ncbi.nlm.nih.gov/pubmed/35488820 http://dx.doi.org/10.37201/req/s01.05.2022

Ejemplares similares

Ceftolozane-tazobactam in nosocomial pneumonia
por: Candel, Francisco Javier, et al.
Publicado: (2022)

New evidence in severe pneumonia: meropenemvaborbactam
por: Guillot, María Forteza, et al.
Publicado: (2022)

New evidence in severe pneumonia: imipenem/ cilastatin/relebactam
por: Girón, Rosa Mª, et al.
Publicado: (2022)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients
por: Rubino, Christopher M., et al.
Publicado: (2021)

Pulmonary Nocardiosis. A case report
por: González-Jiménez, Paula, et al.
Publicado: (2022)

Ceftobiprole: a clinical view
por: Pérez-Crespo, Pedro María Martínez, et al.
Publicado: (2021)

Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
por: Torres, Antonio, et al.
Publicado: (2016)

Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia
por: Hahn, Mark M., et al.
Publicado: (2023)

A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients
por: Bosheva, Miroslava, et al.
Publicado: (2021)

Immune treatment in COVID-19
por: Menéndez, Rosario, et al.
Publicado: (2022)

Prevalence and correlates of treatment failure among Kenyan children hospitalised with severe community-acquired pneumonia: a prospective study of the clinical effectiveness of WHO pneumonia case management guidelines
por: Agweyu, Ambrose, et al.
Publicado: (2014)

Patient Detection of a Drug Dispensing Error by Use of Physician-Provided Drug Samples
por: Ashley, Elizabeth S Dodds, et al.
Publicado: (2002)

Science or Fiction: Use of Nesiritide as a First-Line Agent?
por: Noviasky, John A, et al.
Publicado: (2003)

Assessing the risk of stroke from neck manipulation: a systematic review
por: Haynes, M J, et al.
Publicado: (2012)

Assessment of food habits in children aged 6–12 years and the risk of caries
por: Doichinova, Liliya, et al.
Publicado: (2015)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test
por: Rodríguez Villodres, Angel, et al.
Publicado: (2022)

The effect of intracoronary infusion of bone marrow‐derived mononuclear cells on all‐cause mortality in acute myocardial infarction: rationale and design of the BAMI trial
por: Mathur, Anthony, et al.
Publicado: (2017)

A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction
por: Tita, Cristina, et al.
Publicado: (2017)

Outpatient Antibiotic Prescribing for 357,390 Children With Otitis Media
por: Csonka, Péter, et al.
Publicado: (2022)

Safety and tolerability of ceftobiprole
por: Grau, Santiago
Publicado: (2019)

Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Recurrent ventilator-associated pneumonia caused by “difficult to treat” resistance Pseudomonas aeruginosa
por: Rodríguez-Aguirregabiria, Montserrat, et al.
Publicado: (2022)

Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician
por: Costa, José Ricardo Gimeno
Publicado: (2022)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents
por: Andronikou, Savvas, et al.
Publicado: (2017)

Preliminary report from the World Health Organisation Chest Radiography in Epidemiological Studies project
por: Mahomed, Nasreen, et al.
Publicado: (2017)

Lung ultrasound for the diagnosis of community-acquired pneumonia in children
por: Stadler, Jacob A. M., et al.
Publicado: (2017)

Computed tomography in children with community-acquired pneumonia
por: Andronikou, Savvas, et al.
Publicado: (2017)

Community-acquired pneumonia in children — a changing spectrum of disease
por: le Roux, David M., et al.
Publicado: (2017)

Recent Advances in the Understanding of Acupuncture
por: Liao, Sung J.
Publicado: (1978)

Discussion Summary: Alternatives for Continued Progress
Publicado: (1985)

Do independent treatment centers offer more value than general hospitals? The case of cataract care
por: Kruse, Florien M., et al.
Publicado: (2019)

Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU
por: Daneshnia, Farnaz, et al.
Publicado: (2022)

Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16
por: Martins, Willames M. B. S., et al.
Publicado: (2022)

Pan-drug resistant Providencia rettgeri contributing to a fatal case of COVID-19
por: Mc Gann, Patrick, et al.
Publicado: (2021)

Possible clinical indications of ceftobiprole
por: Barberán, José
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6bqf4ruk9kl69slk2avehcrht4